Drug Delivery

Pulmatrix is developing new breakthrough therapies with the vision of fundamentally changing the way we treat, prevent and control infectious and progressive respiratory diseases.

pSivida is a leading provider of miniaturized, sustained-release drug delivery products and is continuing the evolution of these systems.

Molecular Insight Pharmaceuticals is a clinical-stage biopharmaceutical company and a pioneer in the emerging field of molecular medicine. The Company is focused on the discovery and development of therapeutic radiopharmaceuticals and targeted molecular imaging agents for use in oncology and cardiology.

MicroCHIPS is pioneering intelligent implanted devices designed to improve the health of millions of people with chronic conditions that require careful monitoring and precise therapy.

FEI is a leading diversified scientific instruments company. It is a premier provider of electron and ion-beam microscopes and tools for nanoscale applications across many industries: industrial and academic materials research, life sciences, semiconductors, data storage, natural resources and more. FEI's imaging systems provide 3D characterization, analysis and modification/prototyping with resolutions down to the sub-Angstrom (one-tenth of a nanometer) level.

ExQor's patented bio-nanotransport platform enables delivery of many different types of drugs throughout the body, including the brain. Uniquely and unlike almost all other nano-particles, ExQor's could also become a powerful new therapeutic in its own right.

ExQor's multiple patents cover Clathrin, a vitally essential protein responsible for transporting a very broad variety of substances—from cholesterol to neurotransmitters—to the interior of cells. Clathrin is also implicated in viral diseases, like HIV.

Elan Drug Technologies (EDT) is the world’s leading drug delivery company and is a business unit of Elan (NYSE:ELN). The company focuses on product development, scale-up and manufacturing to address drug optimization challenges of the pharmaceutical industry. Their NanoCrystal® technology is a proven innovation for poorly water-soluble compounds, manufactured to the nanoscale it has five licensed products commercialized to date.

Aphios is developing enabling technology platforms and enhanced therapeutics for health maintenance, disease prevention and the treatment of certain infectious diseases, cancers and CNS disorders.

Ad-Vance Engineers have solved a variety of magnetic shielding problems. In addition, substantial cuts in shielding costs are possible by using our existing tooling. From simple components to complete systems.

Ad-Vance Magnetics offers: Design and Consultation, AD-MU Shielding Alloys, In-House Tool Room for Manufacturing Magnetic Shields, Custom Fabricated CRT Shields, Heat Treating for Optimum Magnetic Shielding Characteristics, State Of The Art Equipment, Processing and Manufacturing, Machining Centers, Precision Laser Cutting

Acusphere is a specialty pharmaceutical company that develops new drugs using our core proprietary microsphere technology. Our technology may be applied to drug targets in a wide variety of clinical applications and disease areas offering potentially significant benefits such as improved safety, efficacy, patient compliance, ease of use, expanded indications or reduced cost. Our current product candidates are designed to advance medical management within cardiology, oncology and pulmonary disease through use of flexible and targeted delivery systems.